Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term intravenous fluids for prevention of post-ERCP pancreatitis (the STRIPE study): protocol for a five-arm randomised controlled trial.

BMJ open·2026
Same author

Sasanlimab taken together with Bacillus Calmette-Guérin (BCG) compared with BCG alone in people with high-risk non-muscle invasive bladder cancer: a plain language summary.

Future oncology (London, England)·2026
Same author

Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.

European urology·2026
Same author

Gastrointestinal Bleeding and Cardiovascular Risk: From Association to Actionable Evidence.

Gastroenterology·2026
Same author

Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.

European urology·2026
Same author

Uncomplicated Choledocholithiasis in Elderly Patients: A Target Trial Emulation Comparing Observation and Endoscopic Retrograde Cholangiopancreatography.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Feb 18, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.7K

Tissue Engineering and Conduit Substitution.

Scott C Johnson1, Zachary L Smith1, Bryan S Sack2

  • 1Department of Surgery, Section of Urology, The University of Chicago, 5841 South Maryland Avenue, MC-6038, Chicago, IL 60637, USA.

The Urologic Clinics of North America
|November 25, 2017
PubMed
Summary
This summary is machine-generated.

Tissue-engineered urinary conduits offer a promising alternative to traditional bowel segments used in radical cystectomy, potentially reducing patient morbidity. Further research in tissue and materials engineering is crucial to overcome current obstacles and advance clinical applications.

Keywords:
Radical cystectomyRegenerative medicineScaffoldsTissue engineeringUrinary diversion

More Related Videos

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

761
Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap
08:05

Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap

Published on: November 3, 2017

7.5K

Related Experiment Videos

Last Updated: Feb 18, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.7K
Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
04:05

Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs

Published on: July 5, 2024

761
Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap
08:05

Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap

Published on: November 3, 2017

7.5K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Urology

Background:

  • Radical cystectomy (RC) necessitates urinary diversion, often using bowel segments.
  • This approach is linked to significant patient morbidity, impacting perioperative and long-term outcomes.
  • Current methods present challenges that a tissue-engineered solution could potentially mitigate.

Purpose of the Study:

  • To explore the potential of tissue-engineered incontinent urinary conduits (TEUC) as an alternative to bowel segments for urinary diversion after RC.
  • To identify key challenges and areas for advancement in the development of TEUCs.
  • To highlight the role of tissue and materials engineering in overcoming these challenges.

Main Methods:

  • Review of existing preclinical attempts at developing TEUCs.
  • Analysis of the role of mechanical scaffolds in promoting tissue growth for urinary conduits.
  • Discussion of the interdisciplinary requirements for TEUC development.

Main Results:

  • Preclinical studies show promise for TEUCs but face significant obstacles.
  • The use of bowel segments in urinary diversion is a primary source of morbidity.
  • Advancements in tissue and materials engineering are needed to overcome current limitations.

Conclusions:

  • Tissue-engineered urinary conduits represent a potential paradigm shift in managing urinary diversion after RC.
  • Overcoming obstacles in TEUC development requires a deeper understanding of tissue and materials engineering principles.
  • Further innovation may lead to novel approaches in regenerative medicine for urological reconstruction.